Revance Therapeutics, Inc. announced the appointment of accomplished biotech and pharmaceutical executive, Olivia C. Ware, and fintech and payments thought leader and entrepreneur, Carey O’Connor Kolaja, to its Board of Directors. The appointments will be made effective on March 1, 2021 for Ms. Kolaja and March 6, 2021, for Ms. Ware. The company also announced that long-standing directors Phyllis Gardner and Robert “Bob” Byrnes have decided that they will be retiring from the board and will not stand for re-election at the company’s 2021 Annual Meeting of Stockholders as part of the company’s 12-year director tenure policy. While the board values director tenure and board continuity, it is also committed to facilitating board refreshment and enhancing diversity. The director tenure policy, established in 2020, aims to ensure that the evolving needs of the board are met with fresh perspectives, skills and reflect broader representation. Ms. Kolaja is currently the Chairman of Everest Effect, a crisis recovery platform, and a board member for Waves for Water.